Clinical Trial: Study of CD38 and CD56 in Chronic Myeloid Leukemia

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740603) titled 'Study of CD38 and CD56 in Chronic Myeloid Leukemia' on July 25.

Brief Summary: Chronic myeloid leukemia is a myelo-proliferative neoplasm characterized by abnormal proliferation of myeloid cells. There is an accumulation of mature granulocytes in the blood and bone marrow.

The aim of the study is to study expression of CD38 and CD56 in patients with Chronic myeloid leukemia.

Study Start Date: July 01

Study Type: OBSERVATIONAL

Condition: Chronic Myeloid Leukemia (CML)

Intervention: DIAGNOSTIC_TEST: cd 38 and cd 56

prescence of high percentage of cd38 and cd 56

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sohag University...